- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04474795
Clinic to Community Connections - Broader Distribution
Clinic to Community Connections: Enhancing Prenatal to Postpartum Care Transitions to Prevent Type 2 Diabetes in Low Income Women With Gestational Diabetes
This study addresses education needs in gestational diabetes care and followup at the staff and patient levels.
In the initial phase, nurses and community health workers will complete specific training modules on gestational diabetes developed for this study. The effectiveness of the education modules will be evaluated through pre/post surveys of participants assessing diabetes knowledge, attitudes, and self-efficacy.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cynthia J Herrick, MD, MPHS
- Phone Number: 314-747-0278
- Email: herrickc@wustl.edu
Study Contact Backup
- Name: Roxann C Williams, MPH
- Phone Number: 314-362-5404
- Email: rcrenshaw@wustl.edu
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63107
- Affinia Healthcare
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Clinic staff: nurses (RN, LPN, BSN), community health workers, and others involved in maternal child health care
Exclusion Criteria:
Clinic staff: individuals not involved in maternal child health care or who do not consent to participate in study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Staff - Educational training
Nurses, community health workers, and others involved in maternal healthcare
|
Nurses and community health workers will complete 4 hours of online modules on gestational diabetes - Module 1: GDM Disease, Diagnosis and Complications; Module 2: Nutrition and Physical Activity Management; Module 3: Monitoring, Medications, and Avoiding Hypoglycemia; Module 4: Future Diabetes Risk and Prevention.
Effectiveness of the training will be evaluated with pre/post evaluation of diabetes knowledge, attitudes, and self efficacy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Staff - Self-efficacy to Provide Diabetes Education Questionnaire (Newly Developed)
Time Frame: Baseline and upon module completion (approximately 3 months)
|
Pre-Post change in staff participants' perceived self-efficacy to provide diabetes education (Mean score min:1 max 10) high score=more confident
|
Baseline and upon module completion (approximately 3 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Staff - Diabetes Attitudes (Diabetes Attitudes Scale-3 (DAS-3))
Time Frame: Baseline and upon module completion (approximately 3 months)
|
Change in diabetes attitudes measured by 3 subscales of DAS-3 (Mean score min 1, max 5) high score=better attitudes
|
Baseline and upon module completion (approximately 3 months)
|
Staff - Diabetes Knowledge Test
Time Frame: Baseline and upon module completion (approximately 3 months)
|
Change in diabetes knowledge measured by multiple choice test (% correct out of 21 items) high score =better knowledge
|
Baseline and upon module completion (approximately 3 months)
|
Staff - Intention to Recommend Diabetes Prevention Activities Questionnaire (Newly Developed)
Time Frame: Baseline and upon module completion (approximately 3 months)
|
Change in staff's intention to recommend postpartum diabetes screening measured by a survey developed for this study (mean score; min 1, max 5) higher score= increased intention to perform action
|
Baseline and upon module completion (approximately 3 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Staff-General Self Efficacy Scale (Schwarzer)
Time Frame: Baseline
|
General Self Efficacy measure (for use in validation of the Self-Efficacy for Providing Diabetes Education Scale) Sum Score (min: 10, max: 40); higher score=more confidence
|
Baseline
|
Staff-Provider Teaching Motivation Questionnaire Intrinsic Motivation Subscale
Time Frame: Baseline
|
Measure of teaching motivation (for use in validation of the Self-Efficacy for Providing Diabetes Education Scale) Mean score (min: 0, max 4) higher score=more intrinsic motivation
|
Baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202007060
- 1K23HD096204-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
-
Royal College of Surgeons, IrelandHealth Research Board, IrelandUnknownPre-Gestational Diabetes
-
University of Colorado, DenverKaiser PermanenteCompletedGestational Diabetes MellitusUnited States
-
Intermountain Health Care, Inc.Withdrawn
-
McGill University Health Centre/Research Institute...The Lawson FoundationCompletedGestational Diabetes Mellitus With Baby DeliveredCanada
-
Woman'sBaton Rouge Area FoundationCompletedGestational Diabetes MellitusUnited States
-
Brigham and Women's HospitalUniversity of Colorado, DenverCompletedGestational Diabetes MellitusUnited States
Clinical Trials on Staff -Educational training
-
Ottawa Hospital Research InstituteHopital Montfort; The Ottawa HospitalNot yet recruitingBurnout, Professional
-
Norwegian Centre for Ageing and HealthThe Research Council of NorwayCompletedDementia | Agitation
-
VA Office of Research and DevelopmentCompletedTobacco UseUnited States
-
PATHGhana Health ServicesCompletedPostpartum HemorrhageGhana
-
University College, LondonUnknownChallenging BehaviourUnited Kingdom
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSmoking Cessation | Second Hand Tobacco SmokeUnited States
-
National Jewish HealthUniversity of ArizonaEnrolling by invitationAsthma in ChildrenUnited States
-
Barcelonabeta Brain Research Center, Pasqual Maragall...Fundacion SARquavitaeCompletedDementia | Alzheimer's DiseaseSpain
-
Emory UniversityNational Institute on Minority Health and Health Disparities (NIMHD); National...Completed
-
Hospital Universitari Vall d'Hebron Research InstituteFundació La Marató de TV3CompletedSatisfaction | Spinal Cord Injury, Acute | Patient Non-Compliance | Professional-Patient Relations | Sensitivity Training GroupsSpain